{"id":"https://openalex.org/W2954624032","doi":"https://doi.org/10.1158/1538-7445.am2019-1323","title":"Abstract 1323: CG-806, a pan-FLT3 / pan-BTK inhibitor, demonstrates superior potency against cells from IDH-1 mutant and other non-favorable risk groups of AML patients","display_name":"Abstract 1323: CG-806, a pan-FLT3 / pan-BTK inhibitor, demonstrates superior potency against cells from IDH-1 mutant and other non-favorable risk groups of AML patients","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W2954624032","doi":"https://doi.org/10.1158/1538-7445.am2019-1323","mag":"2954624032"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2019-1323","doi":"https://doi.org/10.1158/1538-7445.am2019-1323","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-1323","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100420484","display_name":"Hongying Zhang","orcid":"https://orcid.org/0000-0001-8132-5090","observed_orcids":["https://orcid.org/0000-0001-8132-5090","https://orcid.org/0000-0002-5909-4502"]},"institutions":[{"id":"https://openalex.org/I4210162384","display_name":"Aptose Biosciences (United States)","ror":"https://ror.org/053151j41","country_code":"US","type":"company","lineage":["https://openalex.org/I4210162384"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hongying Zhang","raw_affiliation_strings":["1Aptose Biosciences, Inc, San Diego, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Aptose Biosciences, Inc, San Diego, CA;","institution_ids":["https://openalex.org/I4210162384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014765656","display_name":"Andrea Local","orcid":"https://orcid.org/0000-0003-2963-0607","observed_orcids":["https://orcid.org/0000-0003-2963-0607"]},"institutions":[{"id":"https://openalex.org/I4210162384","display_name":"Aptose Biosciences (United States)","ror":"https://ror.org/053151j41","country_code":"US","type":"company","lineage":["https://openalex.org/I4210162384"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrea Local","raw_affiliation_strings":["1Aptose Biosciences, Inc, San Diego, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Aptose Biosciences, Inc, San Diego, CA;","institution_ids":["https://openalex.org/I4210162384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5134831711","display_name":"Jeffrey W Tyner","orcid":"https://orcid.org/0000-0002-2133-0960","observed_orcids":["https://orcid.org/0000-0002-2133-0960"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey W. Tyner","raw_affiliation_strings":["2Knight Cancer Institute, Oregon Health & Science University, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Knight Cancer Institute, Oregon Health & Science University, Portland, OR;","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075070858","display_name":"Stephen E. Kurtz","orcid":"https://orcid.org/0000-0003-4762-389X","observed_orcids":["https://orcid.org/0000-0003-4762-389X"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen E. Kurtz","raw_affiliation_strings":["2Knight Cancer Institute, Oregon Health & Science University, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Knight Cancer Institute, Oregon Health & Science University, Portland, OR;","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010834454","display_name":"Beth Wilmot","orcid":"https://orcid.org/0000-0003-3579-3592","observed_orcids":["https://orcid.org/0000-0003-3579-3592"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Beth Wilmot","raw_affiliation_strings":["2Knight Cancer Institute, Oregon Health & Science University, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Knight Cancer Institute, Oregon Health & Science University, Portland, OR;","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066373576","display_name":"Shannon K. McWeeney","orcid":"https://orcid.org/0000-0001-8333-6607","observed_orcids":["https://orcid.org/0000-0001-8333-6607"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shannon Mcweeney","raw_affiliation_strings":["2Knight Cancer Institute, Oregon Health & Science University, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Knight Cancer Institute, Oregon Health & Science University, Portland, OR;","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125591963","display_name":"Brian J. Druker","orcid":"https://orcid.org/0000-0001-8331-8206","observed_orcids":["https://orcid.org/0000-0001-8331-8206"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian J. Druker","raw_affiliation_strings":["2Knight Cancer Institute, Oregon Health & Science University, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Knight Cancer Institute, Oregon Health & Science University, Portland, OR;","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024148760","display_name":"Stephen B. Howell","orcid":"https://orcid.org/0000-0002-0877-8226","observed_orcids":["https://orcid.org/0000-0002-0877-8226"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen B. Howell","raw_affiliation_strings":["3UC San Diego Moores Cancer Center, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3UC San Diego Moores Cancer Center, San Diego, CA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024503165","display_name":"William G. Rice","orcid":"https://orcid.org/0000-0001-5705-9474","observed_orcids":["https://orcid.org/0000-0001-5705-9474"]},"institutions":[{"id":"https://openalex.org/I4210162384","display_name":"Aptose Biosciences (United States)","ror":"https://ror.org/053151j41","country_code":"US","type":"company","lineage":["https://openalex.org/I4210162384"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William G. Rice","raw_affiliation_strings":["1Aptose Biosciences, Inc, San Diego, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Aptose Biosciences, Inc, San Diego, CA;","institution_ids":["https://openalex.org/I4210162384"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"79","issue":"13_Supplement","first_page":"1323","last_page":"1323"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/flt3-inhibitors","display_name":"FLT3 inhibitors","score":0.7390000224113464},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.9739999771118164},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9909999966621399},{"id":"https://openalex.org/keywords/flt3-itd-mutation","display_name":"FLT3-ITD","score":0.8130000233650208},{"id":"https://openalex.org/keywords/flt3-tyrosine-kinase-domain-mutation","display_name":"FLT3 tyrosine kinase domain mutation","score":0.8240000009536743},{"id":"https://openalex.org/keywords/idh1-mutation","display_name":"IDH1 mutation","score":0.7699999809265137},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.9409999847412109},{"id":"https://openalex.org/keywords/asxl1-mutation","display_name":"ASXL1 mutation","score":0.9900000095367432},{"id":"https://openalex.org/keywords/srsf2-mutation","display_name":"SRSF2 mutation","score":0.9990000128746033},{"id":"https://openalex.org/keywords/midostaurin","display_name":"midostaurin","score":0.8420000076293945},{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":0.7649999856948853},{"id":"https://openalex.org/keywords/crenolanib","display_name":"crenolanib","score":0.8190000057220459},{"id":"https://openalex.org/keywords/quizartinib","display_name":"quizartinib","score":0.7319999933242798},{"id":"https://openalex.org/keywords/drug-sensitivity","display_name":"drug sensitivity","score":0.5220000147819519}],"concepts":[{"id":"https://openalex.org/C2776481607","wikidata":"https://www.wikidata.org/wiki/Q6842945","display_name":"Midostaurin","level":3,"score":0.7801480293273926},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.6773658394813538},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.6735958456993103},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.6171694993972778},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5257954001426697},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.5130618810653687},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.49677973985671997},{"id":"https://openalex.org/C2910954276","wikidata":"https://www.wikidata.org/wiki/Q14912399","display_name":"Fms-Like Tyrosine Kinase 3","level":4,"score":0.4124046564102173},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41151684522628784},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32893434166908264},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32761725783348083},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32049763202667236},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.23929014801979065},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.10487237572669983},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09383189678192139},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2019-1323","doi":"https://doi.org/10.1158/1538-7445.am2019-1323","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-1323","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2886641148","https://openalex.org/W2753691192","https://openalex.org/W2921657174","https://openalex.org/W2887235898","https://openalex.org/W2887058820","https://openalex.org/W2784788133","https://openalex.org/W2785196458","https://openalex.org/W2938682201","https://openalex.org/W2771443296","https://openalex.org/W2953389307"],"abstract_inverted_index":{"Abstract":[0],"CG-806":[1,46,75,128,137,157,199,233,270,316,336,391],"is":[2,9],"a":[3,77,424],"pan-FLT3":[4,425],"/":[5,62,426],"pan-BTK":[6,427],"inhibitor":[7],"that":[8],"more":[10,267],"potent":[11,160],"(IC50":[12],"=":[13],"0.08":[14],"\u00b5M,":[15],"n=265,":[16],"p":[17],"<":[18],"0.001)":[19],"than":[20,296],"other":[21,222,438],"FLT3":[22,57,223,274],"inhibitors":[23,224],"including":[24,225,286,348],"midostaurin,":[25,226],"sorafenib,":[26,227],"sunitinib,":[27,228],"dovitinib,":[28,229],"quizartinib,":[29],"crenolanib":[30,250],"and":[31,68,87,94,99,117,125,144,151,169,177,208,231,249,255,291,351,437],"gilteritinib":[32],"against":[33,50,161,432],"acute":[34],"myeloid":[35],"leukemia":[36],"(AML)":[37],"primary":[38,340],"patient":[39,261,342,361,382],"samples":[40,262,343,362,383],"containing":[41,307],"wild-type":[42],"or":[43,55,183,241],"mutated":[44],"FLT3.":[45],"has":[47,76],"significant":[48],"activity":[49],"AML":[51,71,123,185,341,346,350,443],"cell":[52],"lines":[53],"with":[54,139,181,195,213,239,263,281,289,298,353,363,384],"without":[56],"internal":[58],"tandem":[59],"duplication":[60],"(ITD)":[61],"tyrosine":[63],"kinase":[64],"domain":[65],"(TKD)":[66],"mutations":[67,215,243,288,310,365],"in":[69,81,114,165,203,237,278,339,394],"mouse":[70],"xenograft":[72],"models.":[73],"Oral":[74],"desirable":[78],"safety":[79],"profile":[80],"the":[82,100,109,166,374,379,395,449],"pre-IND":[83],"studies":[84],"of":[85,205,328,381,390,442,448],"rodent":[86,92],"dog":[88],"28-day":[89],"GLP":[90],"toxicology,":[91],"respiratory":[93],"central":[95],"nervous":[96],"system":[97],"safety,":[98],"bacterial":[101],"reverse":[102],"mutation":[103,265],"assay.":[104,134],"The":[105],"current":[106],"study":[107],"explored":[108],"relationship":[110],"between":[111],"genetic":[112,354],"abnormalities":[113,143,355],"bone":[115],"marrow":[116],"peripheral":[118],"mononuclear":[119],"cells":[120,162,178,331,433],"isolated":[121],"from":[122,163,179,193,434],"patients":[124,164,180,194,444],"sensitivity":[126,138,295,314,327,371,380],"to":[127,220,245,253,269,273,315,318,332,357,368,372],"using":[129],"an":[130],"ex":[131],"vivo":[132],"cytotoxicity":[133],"To":[135],"correlate":[136],"clinical":[140,396],"status,":[141],"gene":[142],"expression":[145],"levels,":[146],"whole":[147],"exome":[148],"sequencing":[149,153],"(n=118)":[150],"RNA":[152],"(n=111)":[154],"were":[155,188,216,266,366],"performed.":[156],"was":[158,324,378],"equally":[159],"adverse,":[167],"intermediate":[168],"favorable":[170],"risk":[171,175,440],"groups":[172,441],"(2017":[173],"ELN":[174],"stratification),":[176],"relapsed":[182],"transformed":[184],"(WHO":[186],"classification)":[187],"as":[189,191,271],"sensitive":[190,268],"those":[192,352],"de":[196],"novo":[197],"AML.":[198],"had":[200,234,293],"equivalent":[201],"potency":[202,236,338,431],"cases":[204,212,238,280,297],"TP53":[206,209,214],"WT":[207,275,319],"mutations,":[210,257],"whereas":[211,247],"resistant":[217,252],"(FDR-corrected":[218,276,320],"p<0.1)":[219],"most":[221,375],"quizartinib":[230],"crenolanib.":[232],"similar":[235],"ASXL1":[240,254],"SRSF2":[242,256],"compared":[244,272],"WT,":[246],"sunitinib":[248],"appeared":[251],"respectively.":[258],"As":[259],"expected,":[260],"FLT3-ITD":[264,364],"p<0.01);":[277],"addition,":[279],"high":[282],"ITD":[283],"allelic":[284,300],"ratio,":[285],"concurrent":[287],"NPM1":[290],"DNMT3A,":[292],"greater":[294,313,370],"low":[299],"ratio.":[301],"Most":[302],"unexpectedly,":[303],"all":[304,345],"6":[305],"specimens":[306],"IDH1":[308,385],"R132":[309,386],"demonstrated":[311,337],"significantly":[312],"relative":[317],"p<0.01),":[321],"yet":[322],"there":[323],"no":[325],"increased":[326],"IDH-2":[329],"mutant":[330,436],"CG-806.":[333],"In":[334],"conclusion,":[335],"across":[344],"subgroups":[347],"relapsed/refractory/transformed":[349],"related":[356],"poor":[358],"prognosis.":[359],"While":[360],"expected":[367],"have":[369],"CG-806,":[373,423],"surprising":[376],"correlation":[377],"mutations.":[387],"These":[388],"features":[389],"warrant":[392],"investigation":[393],"setting.":[397],"Citation":[398],"Format:":[399],"Hongying":[400],"Zhang,":[401],"Andrea":[402],"Local,":[403],"Jeffrey":[404],"W.":[405],"Tyner,":[406],"Stephen":[407,417],"E.":[408],"Kurtz,":[409],"Beth":[410],"Wilmot,":[411],"Shannon":[412],"Mcweeney,":[413],"Brian":[414],"J.":[415],"Druker,":[416],"B.":[418],"Howell,":[419],"William":[420],"G.":[421],"Rice.":[422],"inhibitor,":[428],"demonstrates":[429],"superior":[430],"IDH-1":[435],"non-favorable":[439],"[abstract].":[445],"In:":[446],"Proceedings":[447],"American":[450],"Association":[451],"for":[452],"Cancer":[453,467],"Research":[454],"Annual":[455],"Meeting":[456],"2019;":[457],"2019":[458],"Mar":[459],"29-Apr":[460],"3;":[461],"Atlanta,":[462],"GA.":[463],"Philadelphia":[464],"(PA):":[465],"AACR;":[466],"Res":[468],"2019;79(13":[469],"Suppl):Abstract":[470],"nr":[471],"1323.":[472]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2019-07-12T00:00:00"}